Latest

convalescent plasma

·September 19, 2023·6 min read

Is Early Convalescent Plasma Treatment A Barrier to Long COVID?

Researchers found that early treatment with plasma from recovered COVID-19 patients reduces the risk of developing post-COVID conditions or "long COVID." The study revealed that patients who received the plasma, rich in SARS-CoV-2 antibodies, had a reduced hospitalization rate and fewer long COVID symptoms compared to those receiving a placebo.

Featured Genetics Neuroscience

·April 22, 2020·4 min read

Using ‘elite’ antibodies from COVID-19 survivors to develop potent therapies

Researchers are sifting through millions of antibodies produced by those who have recovered from COVID-19 to find which ones neutralize the virus. The team has already identified several antibodies that block coronavirus from interacting with its receptors.

Featured Neuroscience Open Neuroscience Articles

·March 15, 2020·3 min read

Antibodies from COVID-19 survivors could be used to treat patients and protect those at risk

Johns Hopkins University researchers propose using antibodies from the plasma or serum of those who have recovered from COVID-19 to help boost the immunity of newly infected patients and for those at risk of contracting the disease. Researchers say the antibodies may bind to and neutralize SARS-CoV-2. The technique has been proven successful in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic.